|
Moya-Quiles MR, Muro M. Identification of a novel HLA-DPA1 allele, HLA-DPA1*02:102Q. HLA. 2023 Oct;102(4):546-548. doi: 10.1111/tan.15140. Epub 2023 Jun 24. PubMed PMID: 37354083.
AÑO: 2023; IF: 5.9
|
37354083
|
Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Banaclocha HM, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia. Clin Transl Oncol. 2023 May;25(5):1446-1454. doi: 10.1007/s12094-022-03042-z. Epub 2023 Jan 4. PubMed PMID: 36598635.
AÑO: 2023; IF: 2.8
|
|
Del Pozo-Valero M, Corton M, Lopez-Rodriguez R, Mahillo-Fernandez I, Ruiz-Hornillos J, Minguez P, Villaverde C, Perez-Tomas ME, Barreda-Sanchez M, Mancebo E; STOP_Coronavirus Study Group; Paz-Artal E, Guillen-Navarro E, Almoguera B, Ayuso C. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years. Geroscience. 2023 Feb;45(1):543-553. doi: 10.1007/s11357-022-00666-5. Epub 2022 Oct 3. PubMed PMID: 36184726; PubMed Central PMCID: PMC9527133.
AÑO: 2023; IF: 5.3
|
|
Boix F, Jimenez-Coll V, Legaz I, Alfaro R, Moya-Quiles MR, Pena-Moral J, Minguela A, Llorente S, Muro M. Higher Expression of Activated CD8+ T Lymphocytes (CD8+CD25+, CD8+CD69+ and CD8+CD95+) Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients. Front Biosci (Landmark Ed). 2023 Jun 27;28(6):119. doi: 10.31083/j.fbl2806119. PubMed PMID: 37395036.
AÑO: 2023; IF: 3.3
|
|
Blanco G, Lopez-Aventin D, Pujol RM, Gomez-Llonin A, Puiggros A, Lopez-Sanchez M, Estrach T, Garcia-Muret MP, Lopez-Lerma I, Servitje O, Bellosillo B, Muro M, Espinet B, Rabionet R, Gallardo F. High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome. J Clin Lab Anal. 2023 Dec;37(23-24):e24982. doi: 10.1002/jcla.24982. Epub 2023 Dec 19. PubMed PMID: 38115685; PubMed Central PMCID: PMC10756948.
AÑO: 2023; IF: 2.6
|